Virus present up to one month after Zostavax immunization

Some patients inoculated with Zostavax, Merck's shingles vaccine, shed the virus used for the vaccine through their saliva for one month after immunization, according to a researcher from the University of Texas, Houston. Zostavax uses a live accentuated varicella zoster virus to provide protection from shingles, and in January, a retrospective study showed it halved the risk of developing shingles, leading the CDC to recommend all adults over 60 receive the vaccine.

However, says Dr. Catherine DiGiorgio, researchers don't yet know if the varicella virus being shed in saliva and at inoculation sites after immunization is infectious. Despite the potentially sour news, there could be an upside. "It possibly could have use in clinical practice, allowing detection of shingles prior to development of the rash, enabling earlier start of antiviral therapy, and decreasing the duration of shingles and the pain of post-herpetic neuralgia," DiGiorgio said.

In a prospective study, researchers found virus DNA on saliva swabs of more than half of the subjects--21 to be exact--10 minutes after vaccination. Two patients still had varicella DNA on their swabs 28 days after inoculation. Merck's varicella zoster virus is also used in the company's chicken pox vaccine, and there are documented cases of indirect infection from contact with recently vaccinated individuals.

- read the Internal Medicine News article

Free Webinar

What could you do with real-time supply chain information at your fingertips?

Interested in complete supply chain real-time data visibility? Unlock productivity with digital workflows, manage plants inventory with real-time supply chain information and enable faster decision-making with data visualization with pci | bridge. Register today!

Suggested Articles

Implementing data integration strategy in your commercialization breaks down traditional healthcare silos and improves patient outcomes.

With COVID vaccinations expected to start in the coming weeks, 2021 is shaping up to be quite a year for the companies with leading vaccines.

The U.K. became the first Western country to authorize a COVID-19 vaccine, making the Pfizer/BioNTech shot the first mRNA vaccine for widespread use.